Nvidia’s biotech moment; Regeneron launches venture arm; New GLP-1 player enters; Sanofi rejigs cancer pact, vaccine ops; and more

Nvidi­a’s biotech mo­ment; Re­gen­eron launch­es ven­ture arm; New GLP-1 play­er en­ters; Sanofi re­jigs can­cer pact, vac­cine ops; and more Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here. Next month, we will be part­ner­ing with the Fi­nan­cial Times on its US Phar­ma and Biotech Sum­mit re­turns to New York. There are op­tions for both in-per­son and vir­tu­al at­ten­dance — you can find the speak­ers and agen­da here. Unlock this article instantly by becoming a free subscriber. You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.